FORT WORTH, TX, Agusta 2, 2022 (GLOBE NEWSWIRE) - TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) wani kamfani ne na likitanci na asibiti wanda ya ƙware a dandalin Fasahar Fina-Finan Fina-Finan (TFF) don haɓakawa da kasuwancin sabbin samfuran magunguna. , a yau ta sanar da cewa za ta saki sakamakon kwata na biyu na 2022 na sakamakon kudi da nazarin kasuwanci a ranar Alhamis.Agusta 11, 2022, a ƙarshen kasuwannin kuɗin Amurka.
Gudanarwa zai gudanar da kiran taro a 4: 30 pm ET don tattauna sakamakon kudi da samar da sabuntawa game da ci gaban kamfanoni da na asibiti.Za a biyo bayan gabatarwa ta hanyar Q&A tare da masu saka hannun jari.
Kamfanin zai gudanar da kiran taro a ranar Alhamis, 11 ga Agusta, 2022 da karfe 4:30 na yamma ET don nazarin aikin asibiti, kamfanoni da na kudi.Don shiga taron, shiga gidan yanar gizon ko buga ɗaya daga cikin masu zuwa kafin fara kiran:
Kiran kuma za a yi shi kai tsaye kuma ana iya isa ga gidan yanar gizon TFF Pharmaceuticals, https://tffpharma.com ko kai tsaye a https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47. Kiran kuma za a yi shi kai tsaye kuma ana iya isa ga gidan yanar gizon TFF Pharmaceuticals, https://tffpharma.com ko kai tsaye a https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47. Конференция также будет TRANSLIROваться в прямом эфире и DOSTUPNA на веб-sayte TFF Pharmaceuticals https://tffpharma.com . casts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47. Hakanan za'a watsa taron kai tsaye kuma ana samunsu akan gidan yanar gizon TFF Pharmaceuticals https://tffpharma.com ko kai tsaye a https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47.电话会议还将进行网络直播，可以在TFF Pharmaceuticals 的网站https://tffpharma.com 3b9453c47 访问. TFF Pharmaceuticals 的网站https://tffpharma.com 或直接访问https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key34=43 Конференц-связь также будет транслироваться в Интернете и доступна на веб-сайте TFF Pharmaceuticals. https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47. Kiran taron kuma za a yi shi a gidan yanar gizon kuma ana samunsa akan gidan yanar gizon TFF Pharmaceuticals a https://tffpharma.com ko kai tsaye a https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47.Da fatan za a ziyarci gidan yanar gizon kamfanin aƙalla mintuna 15 kafin alƙawarin ku don yin rajista, zazzagewa da shigar da duk software mai jiwuwa da ake buƙata.Hakanan za a buga kiran a duk wata a cikin Kalandar Investor na gidan yanar gizon kamfanin.
Game da TFF PHARMACEUTICALS Thin Film Freezing Technology Platform TFF Pharmaceuticals' fasaha na Thin Film Freezing (TFF) fasaha yana ba da damar mahadi masu wanzuwa da sababbin sinadarai don canza su zuwa busassun foda tare da kaddarorin musamman da fa'idodi.Fim ɗin daskarewa tsari tsari ne na injiniyan barbashi wanda aka tsara don samar da busassun foda tare da kyawawan kaddarorin don inhalation, parenteral, hanci, baka, Topical da hanyoyin kulawa na ido.Ana iya amfani da wannan tsari don haɓaka foda don isar da kai tsaye zuwa wurin da ake so, don haka guje wa matsalolin gudanarwa na tsarin da inganta yanayin rayuwa, saurin fara aiki, da inganta aminci da inganci.Ikon isar da jiyya kai tsaye ga gabobin da aka yi niyya kamar huhu suna ba da damar yin amfani da foda na TFF a ƙananan allurai idan aka kwatanta da abubuwan da aka tsara na baka, rage yawan guba mara amfani da sakamako masu illa.Bayanan dakin gwaje-gwaje sun nuna cewa kaddarorin daskararrun siraran-fim na iya isar da kashi 75% na kashi mai zurfi cikin huhu.Maimakon fallasa zuwa zafi, damuwa mai ƙarfi, ko wasu dakarun da za su iya lalata ƙarin hadaddun hanyoyin warkewa kamar ƙwayoyin cuta masu rauni, daskarewar fim ɗin na ba da damar waɗannan kayan su zama busassun foda waɗanda ke da sauƙin adanawa da kwanciyar hankali, ba da izinin warkewa da alluran rigakafi. don rarrabawa fiye da duniya..Ana iya amfani da fa'idodin daskarewa na bakin ciki don inganta isar da al'ada ko a hade tare da magunguna na zamani na gaba.
GAME DA TFF PHARMACEUTICALS TFF Pharmaceuticals, Inc. wani kamfani ne na asibiti na asibiti wanda ke amfani da fasahar daskarewa mai sauri don haɓakawa da canza magunguna zuwa ingantaccen busassun foda don inganta inganci, aminci da kwanciyar hankali.Kamfanin fasahar fasahar fasahar fim na Thin Film Freezing (TFF) na kamfanin yana da aikace-aikace mai fa'ida kuma yana mai da duk wani magani, gami da alluran rigakafi, kanana da manyan kwayoyin halitta, da ilimin halittu, zuwa busassun foda masu kyau wadanda suke da saukin shakar su kuma sun fi sha, don haka ana iya zama maganin. isarwa.a idanu, hanci da fata na gida.TFF yana da manyan 'yan takarar magunguna guda biyu, voriconazole inhalation foda da tacrolimus inhalation foda, kuma ya ci gaba da fadada fayil dinsa don canza tsarin kiwon lafiyar duniya ta hanyar haɗin gwiwa tare da kamfanoni masu yawa na magunguna, cibiyoyin ilimi da abokan tarayya.Dandalin TFF yana rufe sama da haƙƙin mallaka sama da 120 da aka bayar ko masu jiran aiki a Amurka da wasu ƙasashe.Don ƙarin koyo game da TFF Pharmaceuticals da samfuran ɗan takara, da fatan za a ziyarci gidan yanar gizon kamfanin a https://tffpharma.com.
Safe Harbor Wannan sanarwar manema labarai ta ƙunshi bayanai masu sa ido game da TFF Pharmaceuticals, Inc., gami da tsammanin ci gaba da haɓaka tacrolimus da voriconazole inhaled foda, fa'idodin dandalin TFF na kamfanin, da kuma shirye-shiryen kamfanin don ƙara zuwa layin samfurin ɗan takara na yanzu. .Waɗannan maganganun na gaba sun haɗa da sananne kuma ba a san kasada ba, rashin tabbas da sauran abubuwan da za su iya haifar da sakamako na gaske ya bambanta ta zahiri.Waɗannan abubuwan sun haɗa da: (i) haɗarin cewa kamfanin ba zai iya samun nasarar kammala gwaje-gwaje na asibiti ba ko samun amincewar premarket don tacrolimus ta inhaled, voriconazole foda, ko kowane ɗan takarar busassun foda, (ii) rashin jerin abubuwan. magani a kan dandalin TFF ya sami FDA kafin amincewa ko in ba haka ba jera magungunan kasuwanci, (iii) kamfanin a halin yanzu ba shi da yarjejeniya ko fahimtar duk wani babban kamfanin harhada magunguna don haɓaka magani don haɗawa a cikin dandalin TFF, (iv) da kamfani ba zai iya shiga yarjejeniyar kasuwanci na dogon lokaci tare da kowane ɓangare na uku ba;da (v) wasu hatsarori da aka gano a cikin sashin “Abubuwan Haɗari” na Form 10 na Rahoton Shekara-shekara na kamfanin na 2021 – K, wanda aka shigar da SEC a ranar 24 ga Maris, 2022. TFF Pharmaceuticals ta gargaɗi masu karatu da kada su sanya dogaro ga kowa ko gaba- kallon kalamai.TFF Pharmaceuticals yana ɗauka kuma musamman ya musanta duk wani takalifi don ɗaukaka ko sake duba irin waɗannan maganganun don nuna sabbin yanayi ko yanayin da ba a zata ba, sai dai yadda doka ta buƙata.
TFF Pharmaceuticals Investor Relations Contact: Corey Davis, PhD LifeSci Advisorsscdavis@lifesciadvisors.com 212-915-2577
TFF Pharmaceuticals Media Contact: Gwendolyn SchankerLifeSci Communications(269) 921-3607gschanker@lifescicomms.com
Lokacin aikawa: Agusta-10-2022